Gastrointestinal Diseases Clinical Trials

20 recruiting

Gastrointestinal Diseases Trials at a Glance

20 actively recruiting trials for gastrointestinal diseases are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Boston, Houston, and Portland. Lead sponsors running gastrointestinal diseases studies include Baylor Research Institute, Boston Children's Hospital, and Athens LifeTech Park.

Browse gastrointestinal diseases trials by phase

Treatments under study

About Gastrointestinal Diseases Clinical Trials

Looking for clinical trials for Gastrointestinal Diseases? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastrointestinal Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastrointestinal Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting

Evaluation of Patients With Gastrointestinal Disease

Gastrointestinal DiseasesLower GI Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4,000 enrolled1 locationNCT05041374
Recruiting
Phase 3

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled156 locationsNCT07222800
Recruiting
Phase 1Phase 2

Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.

HealthyGastrointestinal DiseasesAutism Spectrum Disorder
Chang Gung Memorial Hospital60 enrolled1 locationNCT06290258
Recruiting
Not Applicable

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

Postoperative ComplicationsAnastomotic LeaksAnastomotic Complication+8 more
Medtronic - MITG137 enrolled8 locationsNCT07351071
Recruiting
Not Applicable

Trans-nasal Endoscopy for Bariatric Patients

ObesityGastrointestinal DiseasesObese+2 more
Christopher C. Thompson, MD, MSc100 enrolled1 locationNCT06200961
Recruiting
Not Applicable

Foregut Leaks-Role of Microbiome

Gastrointestinal Diseases
Baylor Research Institute50 enrolled1 locationNCT07424469
Recruiting
Not Applicable

Virtual Reality for Non-cardiac Chest Pain

Gastrointestinal DiseasesChest Pain
Mayo Clinic10 enrolled1 locationNCT06262126
Recruiting
Phase 1

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

Metastatic CancerGastrointestinal NeoplasmsGastrointestinal Diseases+2 more
IDRX, Inc., a wholly owned subsidiary of GSK, LLC278 enrolled30 locationsNCT05489237
Recruiting
Not Applicable

PACT Programme for Parents of Children With SHCN

Urologic DiseasesGastrointestinal DiseasesAutism Spectrum Disorder+4 more
Chinese University of Hong Kong196 enrolled2 locationsNCT05467527
Recruiting
Not Applicable

A Personalised Approach Utilising the Frailty Index to Empower Consumers

Gastrointestinal Diseases
Princess Alexandra Hospital, Brisbane, Australia200 enrolled1 locationNCT05292989
Recruiting
Not Applicable

Immune Responses to Gluten

Celiac DiseaseCeliac Disease in ChildrenIntestinal Disease+4 more
Boston Children's Hospital400 enrolled2 locationsNCT05209568
Recruiting

Analytical Validation of Stream™ Platform

Gastrointestinal Diseases
FluidAI Medical50 enrolled1 locationNCT06541431
Recruiting
Not Applicable

SCI-Pex Study - Safety and Performance of PexyEazy®, a Device for Treatment of Hemorrhoids

Gastrointestinal DiseasesRectal DiseasesHemorrhoids+2 more
Developeration AB35 enrolled3 locationsNCT05782010
Recruiting
Not Applicable

A Practice Change for Patients With Severe Chronic, Clinically Unexplained Gastrointestinal Symptoms

Gastrointestinal DiseasesIrritable Bowel Syndrome
The University of Queensland200 enrolled1 locationNCT05274854
Recruiting
Phase 4

Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome

Pathologic ProcessesIntestinal DiseaseGastrointestinal Diseases+5 more
EP Plus Group Sdn Bhd60 enrolled1 locationNCT06271538
Recruiting
Not Applicable

Prevalence Of Significant Endoscopic and Histopathologic Findings in Patients Presenting With Unexplained Iron Deficiency Anemia

Gastrointestinal Diseases
Mansoura University124 enrolled1 locationNCT06430970
Recruiting
Not Applicable

Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.

Head and Neck NeoplasmsEsophageal NeoplasmsNeoplasms+6 more
Taipei Veterans General Hospital, Taiwan20 enrolled1 locationNCT06365866
Recruiting

A Clinical Study to Map the HLA Genomic Region in the Greek Population

Cardiovascular DiseasesMetabolic DiseaseHealthy+7 more
Athens LifeTech Park12,000 enrolled8 locationsNCT06227468
Recruiting
Phase 2

XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma

Gastric CancerGastroesophageal-junction CancerCarcinoma+4 more
The First Affiliated Hospital with Nanjing Medical University80 enrolled1 locationNCT05494060
Recruiting
Phase 2

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients

Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsNeoplasms by Site+8 more
Jiangxi Provincial Cancer Hospital30 enrolled1 locationNCT05252078